Cutler Group LP Red Hill Biopharma Ltd. Call Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Jan 18, 2022	SELL	$2.31 - $5.85 $40,194 - $101,790	-17,400 Reduced 76.32%	5,400 $0
Q3 2021 Oct 26, 2021	BUY	$4.55 - $10.36 $94,640 - $215,488	20,800 Added 1040.0%	22,800 $2,000
Q4 2020 Jan 21, 2021	SELL	$7.81 - $10.39 $781 - $1,039	-100 Reduced 4.76%	2,000 $0
Q3 2020 Oct 27, 2020	SELL	$6.34 - $10.83 $14,582 - $24,909	-2,300 Reduced 52.27%	2,100 $4,000
Q2 2020 Jul 22, 2020	BUY	$4.6 - $8.6 $15,639 - $29,240	3,400 Added 340.0%	4,400 $7,000
Q3 2018 Nov 07, 2018	BUY	$6.0 - $11.35 $6,000 - $11,350	1,000 New	1,000 $0

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $415M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.